Tonix Pharmaceuticals Holding Corp at EBD Group Biotech Showcase Transcript
Noon. Our next presenting company is Tonix Pharmaceuticals Holding Corp., AKA Tonix from Chatham, New Jersey. Tonix is focused on CNS, neurological immunology, and infectious disease. Presenting for the company is its CEO, Seth Lederman.
Thank you all very much for coming. Thank you for the introduction. I'm Seth Lederman, CEO of Tonix Pharmaceuticals. We trade on Nasdaq under the ticker TNXP. And I will be making forward-looking statements, and I refer you to our SEC filings for more complete information about the company.
Going back to the title, this is the first time we're really going to talk about an exciting collaboration with Curia. We have some representatives from Curia here about a new series of antibodies to treat and prevent SARS-CoV-2 related complications. But first, let me tell you about Tonix. We have a mission, it's global. It's ambitious.
We're working in several different areas that were mentioned. And we're really working on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
